ADRs following use of oral COVID-19 therapeutics (Paxlovid, Lagevrio) in New Zealand News item 17 December 2022 Pages: 1 - 1
COMIRNATY Original & Omicron BA.4/BA.5 for children: beware of errors News item 17 December 2022 Pages: 2 - 2
Empagliflozin, dapagliflozin: risk of diabetic ketoacidosis and Fournier's gangrene News item 17 December 2022 Pages: 6 - 6
OCALIVA now contraindicated in advanced primary biliary cholangitis News item 17 December 2022 Pages: 9 - 9
Obesity increases risk of irAEs in patients receiving nivolumab Clinical study 17 December 2022 Pages: 11 - 11
Polypharmacy increases risk of AEs in patients with AF initiating VKAs Clinical study 17 December 2022 Pages: 12 - 12